[Health and economic benefits of mandatory regular vaccination in Slovakia. IV. Measles, rubella and mumps].
The epidemiological situation as regards measles, rubella and mumps in Slovakia before vaccination and after its introduction in 1996, is analysed. On the basis of model costs of treatment of these diseases before vaccination and costs of treatment in 1996 including costs of vaccination, the authors calculated the total saved costs (549.7 mil. Sk), cost-effectiveness (10,680 Sk), as well as the cost-benefit.
Hudecková
H
H
Odbor epidemiológie, Státny zdravotný ústav, Martin.
Straka
S
S
Avdicová
M
M
Rusnáková
S
S
D002648:Child; D003362:Cost-Benefit Analysis; D006801:Humans; D008457:Measles / Q000191:economics* / Q000453:epidemiology* / Q000517:prevention & control; D009107:Mumps / Q000191:economics* / Q000453:epidemiology* / Q000517:prevention & control; D012409:Rubella / Q000191:economics* / Q000453:epidemiology* / Q000517:prevention & control; D018154:Slovakia / Q000453:epidemiology; D014611:Vaccination / Q000191:economics* / Q000331:legislation & jurisprudence